The objective of this study was to investigate the risk of acute internal jugular, subclavian, and axillary deep venous thrombosis (upper torso DVT [UTDVT]) and pulmonary embolism (PE) and the ...

Fintel reports that on January 8, 2025, BTIG downgraded their outlook for Inari Medical (NasdaqGS:NARI) from Buy to Neutral.

Despite guidelines recommending other anticoagulants for people hospitalized with acute pulmonary embolism (PE), old habits ...

Terumo's solid leadership in radial access devices and expanding interventional portfolio present significant growth ...

Published results showed patients who undergo total knee arthroplasty at an altitude of 4,000 feet or higher may be at ...

Thrombosis in women can be life-threatening during pregnancy and hormone therapy. Learn how to manage the risks effectively.

Stryker acquires Inari Medical in a $4.9 billion deal, enhancing its vascular portfolio with innovative VTE treatments and a ...

Stryker said its planned acquisition of Inari Medical would strengthen its position in the peripheral vascular market.

Fintel reports that on January 7, 2025, William Blair downgraded their outlook for Inari Medical (NasdaqGS:NARI) from ...

Medical-device maker Stryker on Monday agreed to acquire Inari Medical , which makes devices that treat patients with venous ...

Risk for venous thromboembolism during pregnancy increased significantly from 2009 to 2019, with an average annual percent ...

Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks Inari Medical ( (NARI) ) has provided an update.